Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

323
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
323
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

340
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
340
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

259
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
259
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

494
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
494
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

472
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
472
Obesity01:24

Obesity

1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Video-tracked <i>Anopheles arabiensis</i> entry and exit behaviour at washed and damaged pyrethroid-treated bednets.

Royal Society open scienceĀ·2024
Same author

Lip, oral and oropharyngeal cancer incidence among Aboriginal and Torres Strait Islander Peoples: First reportĀ from Australian population-based cancer registry, 1999-2018.

Australian dental journalĀ·2024
Same author

Oral and dental symptoms in acute hospital specialist palliative care.

Irish medical journalĀ·2023
Same author

Longitudinal neurodevelopmental profile of a pediatric patient with de novo SPTAN1, epilepsy, and left hippocampal sclerosis.

Epilepsy & behavior reportsĀ·2022
Same author

Letter to the Editor: Healthy for Life: An Innovative and Collaborative Approach to COVID 19 Lockdown in New Zealand.

The Journal of frailty & agingĀ·2020
Same author

Panniculitis with an unusual diagnosis.

Clinical and experimental dermatologyĀ·2019

Related Experiment Video

Updated: Mar 11, 2026

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

1.7K

Compression therapy in an obese patient.

S Thomas1, M Fear2, R Logan3

  • 1Director, Surgical Materials Testing Laboratory, Bridgend.

Journal of Wound Care
|December 3, 2016
PubMed
Summary
This summary is machine-generated.

Compression bandages effectively treat venous leg ulcers in obese men. This study highlights the importance of appropriate compression therapy for managing chronic wounds in individuals with obesity.

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.7K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K

Related Experiment Videos

Last Updated: Mar 11, 2026

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

1.7K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.7K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K

Area of Science:

  • Vascular Medicine
  • Dermatology
  • Wound Care

Background:

  • Venous leg ulcers are chronic wounds often associated with venous insufficiency.
  • Obesity is a significant risk factor and complication in managing venous leg ulcers.
  • Compression therapy is a cornerstone treatment for venous leg ulcers.

Purpose of the Study:

  • To evaluate the efficacy of compression bandages in treating venous leg ulcers in an obese male patient.
  • To assess the impact of obesity on the healing process of venous leg ulcers under compression therapy.

Main Methods:

  • Application of multi-layer compression bandages.
  • Regular wound assessment and dressing changes.
  • Monitoring ulcer size and patient's overall health status.

Main Results:

  • The compression bandages facilitated ulcer healing.
  • Obesity presented challenges but did not preclude successful treatment.
  • Positive wound healing progression was observed.

Conclusions:

  • Compression bandaging is a viable and effective treatment for venous leg ulcers, even in obese patients.
  • Careful patient selection and appropriate application of compression are crucial for successful outcomes.
  • Further research into optimizing compression strategies for obese populations is warranted.